Peer-Reviewed Research

Clinical Efficacy & Data

Rigorous scientific validation underpins every XOVVA formulation. Explore our compendium of independent clinical trials, in-vivo studies, and peer-reviewed whitepapers demonstrating statistically significant outcomes in aesthetic dermatology.

In-Vivo Trial Outcomes

Double-blind, placebo-controlled studies conducted over 12 weeks with quantifiable clinical grading.

DEPIGMENTATION TONEVA

Clinical evaluation of 360° Radiance complex on subjects with severe hyperpigmentation (Fitzpatrick types III-V).

Melanin Index Reduction 42.7%
Erythema Decrease 31.2%
Patient Satisfaction 94.0%
Figure 1.1: Melanin Index Reduction Over Time
50% 25% 0%
Week 2
Week 4
Week 8
42.7%
Week 12
Figure 2.1: Terminal Hair Density Increase
+20% +10% 0%
Baseline Month 3 Month 6
FOLLICULAR VITALITY TRICHOVVA

Quantitative assessment of Anagen Reactivation protocol on mild to moderate androgenetic alopecia.

Hair Density (Terminal) +18.5%
Anagen/Telogen Ratio +24.1%
Reduction in Shedding 62.0%

Research Library

Access full text PDFs of our peer-reviewed publications.

search
description

Efficacy of Novel Peptide Complex in Melasma Management

JOURNAL OF CLINICAL DERMATOLOGY OCT 2023
description

Anagen Phase Prolongation via Follicular Micro-Targeting

INTERNATIONAL TRICHOLOGY REVIEW JAN 2024
description

Safety Profile and Tolerability of High-Concentration Actives

AESTHETIC SCIENCE QUARTERLY AUG 2023